RxDoctor Payments DataLook up a doctor →

John Hwang

Internal Medicine · Harrington Park, NJNPI 1457349177

Payments from drug & device makers

$48,434in general payments, 2019–2025

Across 1,469 payments — averaging $32.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$28K
  • Novo Nordisk$4K
  • Amgen$3K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Boehringer Ingelheim$1K
  • Lilly USA, LLC$975
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)179$27,738
Novo Nordisk454$4,424
Amgen(2 entities)161$2,882
Biohaven Pharmaceuticals, Inc.7$1,288
Boehringer Ingelheim72$1,082
Lilly USA, LLC77$975
AstraZeneca(2 entities)40$689
Incyte Corporation6$663
GSK34$621
Boston Scientific10$619
Otsuka America Pharmaceutical, Inc.32$577
Pfizer35$522
Takeda Pharmaceuticals U.S.A., Inc.27$444
Merck30$417
Axsome Therapeutics, Inc.23$361
Amarin Pharma, Inc.24$328
Kowa Pharmaceuticals America, Inc.23$317
Johnson & Johnson(2 entities)17$313
Jazz Pharmaceuticals Inc.17$252
Corcept Therapeutics13$241
Medtronic4$235
Lundbeck LLC13$222
Sanofi-aventis U.S. LLC13$209
Bayer7$175
Novartis10$159
Exact Sciences7$145
Arbor Pharmaceuticals, Inc.5$143
Nevro Corp.1$142
Esperion Therapeutics, Inc.8$133
Abbott7$126
Axonics, Inc.1$121
Harmony Biosciences LLC8$119
Scilex Pharmaceuticals Inc.7$113
Bausch Health US, LLC6$96
Mannkind Corporation6$92
Avadel CNS Pharmaceuticals, LLC2$89
Astellas Pharma US Inc4$89
Xeris Pharmaceuticals, Inc.5$89
Eisai Inc.6$86
UCB, Inc.4$76
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$73
Shire North American Group Inc5$63
E.r. Squibb & Sons, L.L.C.4$62
Endo Pharmaceuticals Inc.4$59
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$58
Teva Pharmaceuticals USA, Inc.4$55
Vanda Pharmaceuticals Inc.3$48
Insulet Corporation2$40
Azurity Pharmaceuticals, Inc.2$37
Phathom Pharmaceuticals, Inc.2$32
Aerin Medical Inc.1$32
Tolmar, Inc.2$32
Si-bone, Inc.1$30
Idorsia Pharmaceuticals US Inc2$30
Sanofi Pasteur Inc.2$26
Tandem Diabetes Care, Inc.2$23
Dexcom, Inc.1$23
Madrigal Pharmaceuticals1$19
Inspire Medical Systems, Inc.1$19
Lexicon Pharmaceuticals, Inc.1$17

How this compares

$48,434 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024
$295,180
Medicare patients
544
Services billed
5,838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Harrington Park

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →